Safeguard Scientifics Inc (SFE)

13.44
NYSE : Financial
Prev Close 13.24
Day Low/High 13.21 / 13.53
52 Wk Low/High 11.40 / 18.07
Avg Volume 47.80K
Exchange NYSE
Shares Outstanding 20.22M
Market Cap 267.77M
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

MedCrypt Raises $750,000 Seed Round To Develop Medical Device Software Security Platform

MedCrypt Raises $750,000 Seed Round To Develop Medical Device Software Security Platform

Core technology will secure communications between clinicians and connected medical devices at health systems

MicroCap Review Magazine Fall 2016 Issue Now Available

MicroCap Review Magazine Fall 2016 Issue Now Available

The Digital Issue of the Fall 2016 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com

Safeguard Scientifics Names Scott A. Snyder, Ph.D. Chief Technology And Innovation Officer

Safeguard Scientifics Names Scott A. Snyder, Ph.D. Chief Technology And Innovation Officer

New position signals refined focus on technology-enabled businesses as the company leads the next wave of investment opportunities in an era of digital disruption

StockNewsNow.com Publishes New Video Interview With Safeguard Scientifics (NYSE: SFE)

StockNewsNow.com Publishes New Video Interview With Safeguard Scientifics (NYSE: SFE)

CEO Discusses Q2 Earnings, Future Strategy and Investment Focus on Technology

Financial Services Executive, Martina F. Aufiero, Joins Transactis Board

Financial Services Executive, Martina F. Aufiero, Joins Transactis Board

EBPP Leader Also Adds Payments Industry Vets Cindy Hickman and Lisa Gawlak

QuanticMind Blazes New Trail In Paid Search With Record Q2 Revenue

QuanticMind Blazes New Trail In Paid Search With Record Q2 Revenue

Innovative predictive advertising management platform announces unprecedented quarterly revenue, expanded client list, new hires and new product initiatives

Trice Medical Appoints Mark Foster Chief Commercialization Officer

Trice Medical Appoints Mark Foster Chief Commercialization Officer

More than 20 years' experience in global medical technologies strengthens executive team and provides demonstrated leadership in executing commercial strategies

Safeguard Scientifics To Release Second Quarter 2016 Financial Results On Thursday, July 28th

Safeguard Scientifics To Release Second Quarter 2016 Financial Results On Thursday, July 28th

Conference Call and Webcast Scheduled for 9:00am EDT

Aventura Issued U.S. Patent For Updating Virtual Resources & Applications Based On Location

Aventura Issued U.S. Patent For Updating Virtual Resources & Applications Based On Location

Healthcare IT Company Now Holds Eight Patents Related to Situational Awareness Platform that Optimizes Clinical Workflow

Martina F. Aufiero Joins Safeguard Scientifics As Managing Director, Technology

Martina F. Aufiero Joins Safeguard Scientifics As Managing Director, Technology

Brings more than 20 years of investment and operational experience in financial and enterprise technology

Aktana Raises $17.5M To Fund Growing Decision Support Business In Life Sciences

Aktana Raises $17.5M To Fund Growing Decision Support Business In Life Sciences

New Capital Targets International Expansion and Continued Product Development

Technology Innovator Patrick Flynn Joins Aventura As COO

Technology Innovator Patrick Flynn Joins Aventura As COO

Brings More than 30 Years of Technology and Operational Leadership to Pioneering Healthcare IT Situational Awareness Company

Capital One, Fifth Third, PNC, TD, And Wells Fargo Invest In Transactis

Capital One, Fifth Third, PNC, TD, And Wells Fargo Invest In Transactis

Top electronic billing and payment company receives investment from five of the largest U.S. commercial banks

Safeguard Scientifics To Release First Quarter 2016 Financial Results On Thursday, April 28th

Safeguard Scientifics To Release First Quarter 2016 Financial Results On Thursday, April 28th

Conference Call and Webcast Scheduled for 9:00am EDT

Propeller Health And Boehringer Ingelheim Announce New Partnership Focused On Improving Adherence And Care Management For People Living With COPD And Asthma

Propeller Health And Boehringer Ingelheim Announce New Partnership Focused On Improving Adherence And Care Management For People Living With COPD And Asthma

First-of-its-kind commercial partnership between pharmaceutical and digital health companies in respiratory medicine

Safeguard Scientifics Partner Company Putney To Be Acquired For $200M

Safeguard Scientifics Partner Company Putney To Be Acquired For $200M

Safeguard expects to realize $58 million in aggregate cash proceeds, representing an approximate 3.9x cash-on-cash return and 42% IRR

Aventura Selects HealthCast As Its Single Sign-On Partner

Aventura Selects HealthCast As Its Single Sign-On Partner

Partnership Enables Healthcare Organizations to Achieve Basic Desktop Security, Fast Access to Multiple Clinical Applications & Contextual Interoperability

Propeller Partners With Global Drug Delivery Systems Provider Aptar Pharma For Development Of A Next-Generation, Integrated, Connected Metered Dose Inhaler

Propeller Partners With Global Drug Delivery Systems Provider Aptar Pharma For Development Of A Next-Generation, Integrated, Connected Metered Dose Inhaler

Partnership to develop the first digital, connected metered dose inhaler (cMDI) available for the global respiratory pharmaceutical market

Swati Abbott, CEO Of Blue Health Intelligence, Joins Medivo's Board Of Directors

Swati Abbott, CEO Of Blue Health Intelligence, Joins Medivo's Board Of Directors

Abbott to provide strategic guidance and payer analytics expertise as Medivo ramps up its offerings in risk measurement, care management, and HEDIS/Star reporting.

Transactis Is Keeping Banks In The Center Of Payments

Transactis Is Keeping Banks In The Center Of Payments

EBPP leader enters 2016 with strong bank distribution growth

AdvantEdge Healthcare Solutions Provides Billing Confidence

AdvantEdge Healthcare Solutions Provides Billing Confidence

AdvantEdge services reduce risk and improve client confidence in an ever-changing healthcare regulatory environment